Epidemiology, biomarkers, and therapeutic approach in early-stage biliary tract cancers.
1/5 보강
Biliary tract cancer (BTC) represents a heterogeneous group of malignancies, including intrahepatic, perihilar, and distal cholangiocarcinoma, as well as gallbladder cancer.
APA
Hung C, Kong J, et al. (2026). Epidemiology, biomarkers, and therapeutic approach in early-stage biliary tract cancers.. Chinese clinical oncology, 15(1), 8. https://doi.org/10.21037/cco-25-103
MLA
Hung C, et al.. "Epidemiology, biomarkers, and therapeutic approach in early-stage biliary tract cancers.." Chinese clinical oncology, vol. 15, no. 1, 2026, pp. 8.
PMID
41797456 ↗
Abstract 한글 요약
Biliary tract cancer (BTC) represents a heterogeneous group of malignancies, including intrahepatic, perihilar, and distal cholangiocarcinoma, as well as gallbladder cancer. Surgical resection is the only potential curative treatment for early-stage BTC, though outcomes with surgery alone were poor, with high rates of recurrence. In recent years, studies of adjuvant chemotherapy with capecitabine or S-1 have shown improved survival compared to postoperative observation alone. Ongoing clinical trials are incorporating multiple treatment modalities, including radiotherapy, immunotherapy, and targeted therapy. For instance, building on the success of chemo-immunotherapy in the metastatic setting, trials are testing similar designs as adjuvant treatment. The utility of targeted therapies against genetic alterations like FGFR2, IDH1, KRAS, HER2, and SMAD4 in advanced BTC has also spurred exploration of targeted therapy for early-stage BTCs. Various treatment regimens are now also being tested in the neoadjuvant treatment and perioperative setting. The goal of these treatment strategies is to improve surgical outcomes and identify new modalities to reduce recurrence rates of early-stage BTCs. This review provides an overview of the current management landscape of early-stage BTC, presenting the epidemiology and risk factors, reviewing the current management paradigm, and highlighting emerging therapeutic strategies.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.